Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0U3AL
|
|||
| Former ID |
DNCL002582
|
|||
| Drug Name |
Interleukin-12 gene therapy
|
|||
| Indication | Cutaneous T-cell lymphoma [ICD-11: 2B01; ICD-10: C84.0] | Phase 2 | [1] | |
| Melanoma [ICD-11: 2C30] | Phase 2 | [1] | ||
| Merkel cell carcinoma [ICD-11: 2C34; ICD-10: C44] | Phase 2 | [1] | ||
| Company |
OncoSec Medical
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of OncoSec Medical. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.